Milton H Werner - President and CEO, Inhibikase Therapeutics, Inc
As of March 21, 2022
Milton H Werner Net Worth
- Net worth is estimated to be at least $5.69M
- Owns at least 5,317,169 units of Inhibikase Therapeutics, Inc stock
- Sold an estimated value of $77.65K in the last 2 years at Inhibikase Therapeutics, Inc
Milton H Werner Compensation at Inhibikase Therapeutics, Inc in 2020
- Earned a $292,800 salary
- Received a total compensation of $960,719
Milton H Werner Trading
- Largest purchase of shares was 23,589 units , worth over $46.56K on November 19, 2021
- In total has made about 7 transactions over 2 years
- Usually trades in March, with the busiest year in 2022 and 2021
Milton H Werner
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
Milton H Werner Mailing Address
- Mailing address is 3350 Riverwood Parkway Se, Suite 1900 Atlanta GA 30339 GA
Inhibikase Therapeutics, Inc Executive Compensation
Name |
Year
|
Salary
|
Option Awards
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|
| Milton H. Werner, Ph.D. | 2020 | $292,800 | $653,378 | $14,541 | $960,719 |
| Milton H. Werner, Ph.D. | 2019 | $292,800 | $77,276 | $14,541 | $384,617 |
| Joseph Frattaroli, C.P.A. | 2020 | $300,000 | $1,342,220 | - | $1,642,220 |
| Joseph Frattaroli, C.P.A. | 2019 | $300,000 | - | - | $300,000 |
| No matching records found | |||||
Source: https://www.sec.gov/Archives/edgar/data/1750149/000119312521145678/d240505ddef14a.htm
Inhibikase Therapeutics, Inc Insider Trading
- The most recent transaction was 23,589 units bought on November 19, 2021 by Milton H Werner worth over $46.56K
- In the years Inhibikase Therapeutics, Inc was active, insiders at Inhibikase Therapeutics, Inc sold an estimated value of $77.65K and bought an estimated value of $592.88K
- The most active traders are Milton H Werner, President and CEO, Joseph Frattaroli, Chief Financial Officer, and Dennis Berman, Director
- Insider trading is most common in December, with the busiest year in 2021
Inhibikase Therapeutics, Inc. Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||